Qiagen NV
QGEN
View Detailed Chart
45.000USD
-0.220-0.49%
Market hours （ET）Quotes delayed by 15 min
9.76BMarket Cap
24.10P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.49%
5 Days
-4.28%
1 Month
+1.53%
6 Months
-4.48%
Year to Date
+1.07%
1 Year
-0.87%
View Detailed Chart
TradingKey Stock Score of Qiagen NV
Currency: USD Updated: 2025-12-12Key Insights
Qiagen NV's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 29/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 50.65.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Qiagen NV's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
18
analysts
Buy
Current Rating
50.653
Target Price
+10.45%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Qiagen NV Highlights
StrengthsRisks
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Undervalued
The company’s latest PE is 24.22, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 177.81M shares, decreasing 15.39% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 5.37K shares of this stock.
Qiagen NV News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Qiagen NV Info
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Ticker SymbolQGEN
CompanyQiagen NV
CEOBernard (Thierry)
Websitehttps://www.qiagen.com/
FAQs
What is the current price of Qiagen NV (QGEN)?
The current price of Qiagen NV (QGEN) is 45.000.
What is the symbol of Qiagen NV?
The ticker symbol of Qiagen NV is QGEN.
What is the 52-week high of Qiagen NV?
The 52-week high of Qiagen NV is 51.875.
What is the 52-week low of Qiagen NV?
The 52-week low of Qiagen NV is 37.630.
What is the market capitalization of Qiagen NV?
The market capitalization of Qiagen NV is 9.76B.
What is the net income of Qiagen NV?
The net income of Qiagen NV is 83.59M.
Is Qiagen NV (QGEN) currently rated as Buy, Hold, or Sell?
According to analysts, Qiagen NV (QGEN) has an overall rating of Buy, with a price target of 50.653.
What is the Earnings Per Share (EPS TTM) of Qiagen NV (QGEN)?
The Earnings Per Share (EPS TTM) of Qiagen NV (QGEN) is 1.867.
Related Instruments
+3.14%
+1.18%
+1.62%
+1.32%
+1.40%
-0.15%
+1.48%
+0.33%
+2.03%
+0.28%
-2.69%
-0.16%
+3.34%
+0.52%
+0.63%
+2.99%
+1.70%
0.00%
+1.33%
-0.14%Popular Symbols
